New Zealand markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.24-0.05 (-0.69%)
At close: 04:00PM EST
7.30 +0.06 (+0.83%)
After hours: 07:55PM EST
Full screen
Trade prices are not sourced from all markets
Previous close7.29
Open6.93
Bid0.00 x 3100
Ask0.00 x 1800
Day's range6.91 - 7.32
52-week range5.81 - 19.00
Volume6,596,468
Avg. volume3,666,578
Market cap1.523B
Beta (5Y monthly)0.58
PE ratio (TTM)N/A
EPS (TTM)-1.11
Earnings date28 Feb 2022 - 04 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.00
  • Motley Fool

    Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen

    Inovio Pharmaceuticals (NASDAQ: INO) and Ocugen (NASDAQ: OCGN) are two small biotechs that hope to win regulatory authorizations for COVID-19 vaccines in the not-too-distant future. In this Motley Fool Live video recorded on Nov. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how these two COVID-19 contenders stack up against each other. Keith Speights: There are two companies that hope to market COVID-19 vaccines: Inovio and Ocugen.

  • Motley Fool

    3 Vaccine Latecomers That Could Double Your Money

    Experts predict the coronavirus will stick around -- so a potential end to the pandemic wouldn't necessarily equal an end to the need for vaccination. In fact, you may see bigger returns from an investment in a smaller biotech company that hasn't yet reached the vaccine finish line. Positive clinical trial reports or regulatory submissions could be major catalysts.

  • Motley Fool

    Does This News Make Inovio Pharmaceuticals Stock a Buy?

    The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing?